The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or analogs structurally related to those autoantigens, which are specific for the particular autoimmune disease....http://www.google.fr/patents/US6019971?utm_source=gb-gplus-shareBrevet US6019971 - Treatment of autoimmune arthritis by oral administration of collagen
Treatment of autoimmune arthritis by oral administration of collagen
